Publication Date
1-16-2025
Content Type
Article
PubMed ID:
Citation
Lee, H. J., Ramchandren, R., Friedman, J., Melear, J., Flinn, I. W., Burke, J. M., Linhares, Y., Gonzales, P., Peterson, M., Raval, M., Chintapatla, R., Feldman, T. A., Yimer, H., Islas-Ohlmayer, M., Patel, A., Metheny, L., Dean, A., Rana, V., Gandhi, M. D., Renshaw, J., … Yasenchak, C. A. (2025). Brentuximab vedotin, nivolumab, doxorubicin, and dacarbazine for advanced-stage classical Hodgkin lymphoma. Blood, 145(3), 290–299. https://doi.org/10.1182/blood.2024024681
Restricted
Available to BHSF community via local IP address or BHSF login.